I.DagogoJackMD(@IbiayiMD) 's Twitter Profileg
I.DagogoJackMD

@IbiayiMD

Thoracic Oncologist at MGH. Lung cancer and mesothelioma researcher. Views are my own.

ID:1171946066763231232

calendar_today12-09-2019 00:38:26

20 Tweets

790 Followers

84 Following

Follow People
Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo

Dr. I.DagogoJackMD will discuss (both V600E and non) in NSCLC at on Saturday, October 7, 2023. How should we sequence therapy in this important subtype? New options? Full agenda, faculty and registration at: medstarhealth.org/dclung23

Dr. @IbiayiMD will discuss #BRAF (both V600E and non) in NSCLC at #DCLung23 on Saturday, October 7, 2023. How should we sequence therapy in this important subtype? New options? Full agenda, faculty and registration at: medstarhealth.org/dclung23
account_circle
OncLive.com(@OncLive) 's Twitter Profile Photo

Registration is open! Join I.DagogoJackMD of Mass General Cancer Center as she chairs an OncLive SOSS Lung Cancer in-person education and networking event on 6/21 at 6:00 PM!

Register Today: ow.ly/PfIy50OpvGf

Registration is open! Join @IbiayiMD of @MGHCancerCenter as she chairs an @OncLiveSOSS Lung Cancer in-person education and networking event on 6/21 at 6:00 PM! #SOSS Register Today: ow.ly/PfIy50OpvGf
account_circle
Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo

Online PeerView CME activity now available with Dr. I.DagogoJackMD and me discussing 'Perfecting Precision in Modern NSCLC Practice: Are You Optimally Integrating Biomarker-Driven Therapy?'

lrn.peerview.com/150207968_1/15…

Online @PeerView CME activity now available with Dr. @IbiayiMD and me discussing 'Perfecting Precision in Modern NSCLC Practice: Are You Optimally Integrating Biomarker-Driven Therapy?' lrn.peerview.com/150207968_1/15…
account_circle
Stephen V Liu, MD(@StephenVLiu) 's Twitter Profile Photo

Tomorrow! Multi-tumor symposium with Research To Practice & Research to Practice, live or virtual, with the North Carolina Oncology Association & South Carolina Oncology Society 2023 meeting. Dr. I.DagogoJackMD and I will discuss the lung cancer updates! Register now!

researchtopractice.com/Meetings/NCOA-…

Tomorrow! Multi-tumor symposium with @DrNeilLove & Research to Practice, live or virtual, with the North Carolina Oncology Association & South Carolina Oncology Society 2023 meeting. Dr. @IbiayiMD and I will discuss the lung cancer updates! Register now! researchtopractice.com/Meetings/NCOA-…
account_circle
I.DagogoJackMD(@IbiayiMD) 's Twitter Profile Photo

MET amp identified at resistance to 2nd-gen ALK TKIs (12%) and lorlatinib (22%). ALK+ NSCLC with MET amp responds to lorlatinib + crizotinib. Phase I/II trial coming soon. We must test for MET amp.
clincancerres.aacrjournals.org/content/early/…

account_circle